Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2

Surabhi Dangi-Garimella*, Seth B. Krantz, Morgan R. Barron, Mario A. Shields, Michael J. Heiferman, Paul J. Grippo, David J. Bentrem, Hidayatullah G. Munshi

*Corresponding author for this work

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

One of the hallmarks of human pancreatic ductal adenocarcinoma (PDAC) is its pronounced type I collagen-rich fibrotic reaction. Although recent reports have shown that the fibrotic reaction can limit the efficacy of gemcitabine chemotherapy, the underlying mechanisms remain poorly understood. In this article, we show that the type I collagen allows PDAC cells to override checkpoint arrest induced by gemcitabine. Relative to cells grown on tissue culture plastic, PDAC cells grown in 3-dimensional collagen microenvironment have minimal Chk1 phosphorylation and continue to proliferate in the presence of gemcitabine. Collagen increases membrane type 1 matrix metalloproteinase (MT1-MMP)-dependent ERK1/2 phosphorylation to limit the effect of gemcitabine. Collagen also increases MT1-MMP-dependent high mobility group A2 (HMGA2) expression, a nonhistone DNA-binding nuclear protein involved in chromatin remodeling and gene transcription, to attenuate the effect of gemcitabine. Overexpression of MT1-MMP in the collagen microenvironment increases ERK1/2 phosphorylation and HMGA2 expression, and thereby further attenuates gemcitabine-induced checkpoint arrest. MT1-MMP also allows PDAC cells to continue to proliferate in the presence of gemcitabine in a xenograft mouse model. Clinically, human tumors with increased MT1-MMP show increased HMGA2 expression. Overall, our data show that collagen upregulation of MT1-MMP contributes to gemcitabine resistance in vitro and in a xenograft mouse model, and suggest that targeting MT1-MMP could be a novel approach to sensitize pancreatic tumors to gemcitabine.

Original languageEnglish (US)
Pages (from-to)1019-1028
Number of pages10
JournalCancer Research
Volume71
Issue number3
DOIs
StatePublished - Feb 1 2011

Fingerprint

gemcitabine
Matrix Metalloproteinase 14
Pancreatic Neoplasms
varespladib methyl
Collagen
Adenocarcinoma
Phosphorylation
Collagen Type I
Heterografts
Chromatin Assembly and Disassembly
DNA-Binding Proteins
Nuclear Proteins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Dangi-Garimella, Surabhi ; Krantz, Seth B. ; Barron, Morgan R. ; Shields, Mario A. ; Heiferman, Michael J. ; Grippo, Paul J. ; Bentrem, David J. ; Munshi, Hidayatullah G. / Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. In: Cancer Research. 2011 ; Vol. 71, No. 3. pp. 1019-1028.
@article{44d1b4926ef54560a7961b08972bb8be,
title = "Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2",
abstract = "One of the hallmarks of human pancreatic ductal adenocarcinoma (PDAC) is its pronounced type I collagen-rich fibrotic reaction. Although recent reports have shown that the fibrotic reaction can limit the efficacy of gemcitabine chemotherapy, the underlying mechanisms remain poorly understood. In this article, we show that the type I collagen allows PDAC cells to override checkpoint arrest induced by gemcitabine. Relative to cells grown on tissue culture plastic, PDAC cells grown in 3-dimensional collagen microenvironment have minimal Chk1 phosphorylation and continue to proliferate in the presence of gemcitabine. Collagen increases membrane type 1 matrix metalloproteinase (MT1-MMP)-dependent ERK1/2 phosphorylation to limit the effect of gemcitabine. Collagen also increases MT1-MMP-dependent high mobility group A2 (HMGA2) expression, a nonhistone DNA-binding nuclear protein involved in chromatin remodeling and gene transcription, to attenuate the effect of gemcitabine. Overexpression of MT1-MMP in the collagen microenvironment increases ERK1/2 phosphorylation and HMGA2 expression, and thereby further attenuates gemcitabine-induced checkpoint arrest. MT1-MMP also allows PDAC cells to continue to proliferate in the presence of gemcitabine in a xenograft mouse model. Clinically, human tumors with increased MT1-MMP show increased HMGA2 expression. Overall, our data show that collagen upregulation of MT1-MMP contributes to gemcitabine resistance in vitro and in a xenograft mouse model, and suggest that targeting MT1-MMP could be a novel approach to sensitize pancreatic tumors to gemcitabine.",
author = "Surabhi Dangi-Garimella and Krantz, {Seth B.} and Barron, {Morgan R.} and Shields, {Mario A.} and Heiferman, {Michael J.} and Grippo, {Paul J.} and Bentrem, {David J.} and Munshi, {Hidayatullah G.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1158/0008-5472.CAN-10-1855",
language = "English (US)",
volume = "71",
pages = "1019--1028",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. / Dangi-Garimella, Surabhi; Krantz, Seth B.; Barron, Morgan R.; Shields, Mario A.; Heiferman, Michael J.; Grippo, Paul J.; Bentrem, David J.; Munshi, Hidayatullah G.

In: Cancer Research, Vol. 71, No. 3, 01.02.2011, p. 1019-1028.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2

AU - Dangi-Garimella, Surabhi

AU - Krantz, Seth B.

AU - Barron, Morgan R.

AU - Shields, Mario A.

AU - Heiferman, Michael J.

AU - Grippo, Paul J.

AU - Bentrem, David J.

AU - Munshi, Hidayatullah G.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - One of the hallmarks of human pancreatic ductal adenocarcinoma (PDAC) is its pronounced type I collagen-rich fibrotic reaction. Although recent reports have shown that the fibrotic reaction can limit the efficacy of gemcitabine chemotherapy, the underlying mechanisms remain poorly understood. In this article, we show that the type I collagen allows PDAC cells to override checkpoint arrest induced by gemcitabine. Relative to cells grown on tissue culture plastic, PDAC cells grown in 3-dimensional collagen microenvironment have minimal Chk1 phosphorylation and continue to proliferate in the presence of gemcitabine. Collagen increases membrane type 1 matrix metalloproteinase (MT1-MMP)-dependent ERK1/2 phosphorylation to limit the effect of gemcitabine. Collagen also increases MT1-MMP-dependent high mobility group A2 (HMGA2) expression, a nonhistone DNA-binding nuclear protein involved in chromatin remodeling and gene transcription, to attenuate the effect of gemcitabine. Overexpression of MT1-MMP in the collagen microenvironment increases ERK1/2 phosphorylation and HMGA2 expression, and thereby further attenuates gemcitabine-induced checkpoint arrest. MT1-MMP also allows PDAC cells to continue to proliferate in the presence of gemcitabine in a xenograft mouse model. Clinically, human tumors with increased MT1-MMP show increased HMGA2 expression. Overall, our data show that collagen upregulation of MT1-MMP contributes to gemcitabine resistance in vitro and in a xenograft mouse model, and suggest that targeting MT1-MMP could be a novel approach to sensitize pancreatic tumors to gemcitabine.

AB - One of the hallmarks of human pancreatic ductal adenocarcinoma (PDAC) is its pronounced type I collagen-rich fibrotic reaction. Although recent reports have shown that the fibrotic reaction can limit the efficacy of gemcitabine chemotherapy, the underlying mechanisms remain poorly understood. In this article, we show that the type I collagen allows PDAC cells to override checkpoint arrest induced by gemcitabine. Relative to cells grown on tissue culture plastic, PDAC cells grown in 3-dimensional collagen microenvironment have minimal Chk1 phosphorylation and continue to proliferate in the presence of gemcitabine. Collagen increases membrane type 1 matrix metalloproteinase (MT1-MMP)-dependent ERK1/2 phosphorylation to limit the effect of gemcitabine. Collagen also increases MT1-MMP-dependent high mobility group A2 (HMGA2) expression, a nonhistone DNA-binding nuclear protein involved in chromatin remodeling and gene transcription, to attenuate the effect of gemcitabine. Overexpression of MT1-MMP in the collagen microenvironment increases ERK1/2 phosphorylation and HMGA2 expression, and thereby further attenuates gemcitabine-induced checkpoint arrest. MT1-MMP also allows PDAC cells to continue to proliferate in the presence of gemcitabine in a xenograft mouse model. Clinically, human tumors with increased MT1-MMP show increased HMGA2 expression. Overall, our data show that collagen upregulation of MT1-MMP contributes to gemcitabine resistance in vitro and in a xenograft mouse model, and suggest that targeting MT1-MMP could be a novel approach to sensitize pancreatic tumors to gemcitabine.

UR - http://www.scopus.com/inward/record.url?scp=79551509386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551509386&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-10-1855

DO - 10.1158/0008-5472.CAN-10-1855

M3 - Article

C2 - 21148071

AN - SCOPUS:79551509386

VL - 71

SP - 1019

EP - 1028

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 3

ER -